Physician profile
Susan Hunter
NPI 1477558401
$2,225.02
in general payments reported to CMS, 2019-2025
13 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $164 · 2021: $119 · 2022: $319 · 2023: $419 · 2024: $200 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.17 |
| Education | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $851.97 | 2019-2021 | |
| Evofem Biosciences, INC. | $345.70 | 2022-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $265.05 | 2019-2025 | |
| Astellas Pharma US INC | $251.40 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $177.04 | 2022 | |
| Coopersurgical, INC. | $87.25 | 2023-2025 | Ally II Ups, Paragard T 380a |
| Femselect INC. | $69.71 | 2023 | Enplace |
| Sumitomo Pharma America, INC. | $60.66 | 2023-2025 | Myfembree |
| Organon LLC | $50.80 | 2022-2024 | |
| Pfizer INC. | $35.60 | 2022-2024 | |
| Exeltis, USA INC. | $15.65 | 2023 | Slynd |
| Allergan, INC. | $14.19 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.